Last reviewed · How we verify

NCT06589063: LOW-TAVR

Transcatheter Aortic Valve Replacement in Severe Low Flow, Low Gradient Aortic Stenosis

Recruiting now Last updated 7 April 2026
What this trial tests

trial testing Transcatheter aortic valve replacement in Low Flow, Low Gradient Aortic Stenosis in 1,350 participants. Currently enrolling.

Timeline
1 March 2024
Primary endpoint
1 September 2025
31 December 2037

Quick facts

Lead sponsorUniversity of Salerno
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment1,350
Start date1 March 2024
Primary completion1 September 2025
Estimated completion31 December 2037
Sites1 location across Italy

Drugs / interventions tested

Conditions studied

Sponsor

University of Salerno

Who can join

18 and older, any sex, with Low Flow, Low Gradient Aortic Stenosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

LOW-TAVR is a real-world, retrospective and prospective, multicenter Italian registry aimed at evaluating the characteristics and clinical outcomes of patients with severe low flow, low gradient aortic stenosis undergoing transcatheter aortic valve replacement (TAVR) and, in particular: * risk factors * gender differences * comorbidities * pharmacological treatment * TAVR procedural characteristics * periprocedural and in-hospital complications * clinical outcome at 30-day, 1-year, 2-year and 5-year follow-up

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Balloon-Expandable Versus Self-Expanding Prostheses for Transcatheter Treatment of Patients With Low-Flow, Low-Gradient Aortic Stenosis.
    Ferruzzi GJ, Bellino M, Silverio A, Saia F, et al · · 2026 · PMID 42132173 · DOI 10.1161/jaha.125.046441

Verify or expand the search:

Other trials of Transcatheter aortic valve replacement

Trials testing the same drug.

Other University of Salerno trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06589063.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing